SCHEMBL6895721

SCHEMBL6895721

CCOCn1nnc(-c2ccc(Cl)cc2)c1-c1ccnc(NC(C)c2ccccc2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.54
MAPK13 O15264 6/20 0.47
PRKD3 O94806 1/20 0.47
MAP4K4 O95819 1/20 0.47
LCK P06239 1/20 0.47
LYN P07948 1/20 0.47
MAPK1 P28482 1/20 0.47
AKT2 P31751 1/20 0.47
FLT4 P35916 1/20 0.47
FLT3 P36888 1/20 0.47
FRK P42685 1/20 0.47
MAPK8 P45983 1/20 0.47
MAPK9 P45984 1/20 0.47
CSNK1A1 P48729 1/20 0.47
CSNK1D P48730 1/20 0.47
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47
CSNK1G2 P78368 1/20 0.47
MAP4K2 Q12851 1/20 0.47
DYRK1A Q13627 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6790483 0.85 DYRK1A (0.48) MAPK14MAPK13MAPK9GSK3BDYRK1A
SCHEMBL6895717 0.82 MKNK1 (0.42) MAPK14DYRK1ACLK4
SCHEMBL6790123 0.82 MAPK14 (0.58) MAPK14MAPK13PRKD3MAP4K4LCK
SCHEMBL6612309 0.80 MAPK14 (0.54) MAPK14MAP4K4FRKMAPK9CSNK1D
SCHEMBL6768581 0.79 MAPK14 (0.44) MAPK14
SCHEMBL6790478 0.78 MAPK14 (0.44) MAPK14GSK3BDYRK1A
SCHEMBL6895713 0.78 MAPK14 (0.43) MAPK14
SCHEMBL6783578 0.78 DYRK1A (0.48) MAPK14MAPK13LCKMAPK9GSK3B
SCHEMBL6783824 0.77 MAPK14 (0.59) MAPK14MAPK13PRKD3MAP4K4LCK
SCHEMBL6783821 0.77 MAPK14 (0.59) MAPK14MAPK13PRKD3MAP4K4LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6787555-B2 SUCH AS 4-(4-FLUOROPHENYL)-5-(2-PHENYLMETHYLAMINO)PYRIMIDIN-4-YL)-1-ETHOXYMETHYL -(1,2,3)TRIAZOLE FOR INHIBITION OF RELEASE OF INFLAMMATORY INTERLEUKINS; FOR TREATMENT OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, AND CONGESTIVE HEART FAILURE THE PROCTER & GAMBLE COMPANY 2004-09-07 US claimed